Sugi Predict

Sugi Predict / Compounds / SCHEMBL1406795

SCHEMBL1406795

SCHEMBL1406795

O=C(O)c1cnn(C2CCCCC2)c1C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ ACHE P22303 1/20 0.40
▸ HSD11B1 P28845 2/20 0.38
▸ MPO P05164 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KEAP1 Q14145 1/20 0.37
▸ NFE2L2 Q16236 1/20 0.37
▸ HCAR3 P49019 1/20 0.37
▸ KDM5A P29375 1/20 0.37
▸ KDM4C Q9H3R0 1/20 0.37
▸ KDM5B Q9UGL1 1/20 0.37
▸ SPR P35270 1/20 0.37
▸ NR3C1 P04150 2/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ DDR1 Q08345 1/20 0.37
▸ MAPK11 Q15759 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27172741 1.00 POLB (0.48) POLBMAPTSMN1; SMN2ACHEHSD11B1
SCHEMBL1406647 0.98 POLB (0.49) POLBMAPTSMN1; SMN2ACHEHSD11B1
SCHEMBL1407231 0.95 POLB (0.49) POLBMAPTSMN1; SMN2ACHEHSD11B1
SCHEMBL1406966 0.92 MAPT (0.51) POLBMAPTSMN1; SMN2HSD11B1KDM4E
SCHEMBL28613582 0.91 MAPT (0.50) POLBMAPTSMN1; SMN2HSD11B1KDM4E
Potassium SCHEMBL31133556 0.91 MAPT (0.50) POLBMAPTSMN1; SMN2HSD11B1KDM4E
Hydrochloric Acid SCHEMBL5680592 0.90 MAPT (0.40) POLBMAPTSMN1; SMN2ACHEHSD11B1
SCHEMBL1407186 0.87 POLB (0.47) POLBMAPTSMN1; SMN2HSD11B1KDM4E
SCHEMBL1407022 0.87 POLB (0.47) POLBMAPTSMN1; SMN2HSD11B1KDM4E
SCHEMBL1407020 0.87 POLB (0.47) POLBMAPTSMN1; SMN2HSD11B1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295411-A1 Pyrazoles as 11-beta-hsd-1 F. Hoffmann-La Roche AG (CH) 2011-03-16 — — EP claimed
EP-1999114-A2 PYRAZOLES AS 11-BETA-HSD-1 F. Hoffmann-la Roche AG (CH) 2008-12-10 — — EP claimed
WO-2007107470-A2 PYRAZOLES AS 11-BETA-HSD-1 F. HOFFMANN-LA ROCHE AG (CH) 2007-09-27 — — WO claimed
US-20240316017-A1 NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR LG CHEM, LTD. (KR) 2024-09-26 — — US disclosed
US-20240300944-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR LG CHEM, LTD. (KR) 2024-09-12 — — US disclosed
EP-4349826-A1 NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR LG Chem, Ltd. (KR) 2024-04-10 — — EP disclosed
EP-4339197-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR Lg Chem, Ltd. (KR) 2024-03-20 — — EP disclosed
CN-117500805-A Novel urea derivative compounds as RON inhibitors 株式会社LG化学 2024-02-02 — — CN disclosed
CN-117412958-A Novel pyridine derivative compounds as RON inhibitors 株式会社LG化学 2024-01-16 — — CN disclosed
WO-2022270977-A1 NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR 주식회사 엘지화학 2022-12-29 — — WO disclosed
EP-2227453-B1 HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS VERTEX PHARMA (US) 2016-03-09 — — EP disclosed
US-7728029-B2 Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase HOFFMANN-LA ROCHE INC. (US) 2010-06-01 — — US disclosed
WO-2009049180-A2 HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-04-16 — — WO disclosed
US-20090099233-A1 HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2009-04-16 — — US disclosed
CN-101405270-A Pyrazoles as 11-beta-HSD-1 HOFFMANN LA ROCHE (CH) 2009-04-08 — — CN disclosed
EP-1999114-A2 PYRAZOLES AS 11-BETA-HSD-1 F. Hoffmann-la Roche AG (CH) 2008-12-10 — — EP disclosed
WO-2007107470-A2 PYRAZOLES AS 11-BETA-HSD-1 F. HOFFMANN-LA ROCHE AG (CH) 2007-09-27 — — WO disclosed
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase ANDERSON KEVIN WILLIAM 2007-09-27 — — US disclosed
US-20050020564-A1 Pyrazole-amides and sulfonamides as sodium channel modulators ABBOTT LABORATORIES 2005-01-27 — — US disclosed
US-20040220170-A1 Pyrazole-amides and sulfonamides as sodium channel modulators ABBOTT LABORATORIES 2004-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase HSD3B2, HSD3B1, HSD17B2 POLB 1549/4885MAPT 4272/4885SMN1; SMN2 3959/4885
US-20090099233-A1 HETEROARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS CACNA1B, SCN3A, SCN2A POLB 4632/4885MAPT 3054/4885SMN1; SMN2 1406/4885
US-20240316017-A1 NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR RET, ROS1, MST1R POLB 4598/4885MAPT 4155/4885SMN1; SMN2 4287/4885
US-20240300944-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR CDKN1A, RET, UBTF POLB 3957/4885MAPT 2721/4885SMN1; SMN2 4350/4885
US-20050020564-A1 Pyrazole-amides and sulfonamides as sodium channel modulators SCN3A, KCNN3, TRPV3 POLB 4785/4885MAPT 4316/4885SMN1; SMN2 395/4885
US-20040220170-A1 Pyrazole-amides and sulfonamides as sodium channel modulators SCN3A, KCNN3, TRPV3 POLB 4785/4885MAPT 4316/4885SMN1; SMN2 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.